...Merck Research Laboratories. In June, the pharma received approval for an sBLA of its Zerbaxa ceftolozane/tazobactam...
...bacteria. In a Phase III trial to treat hospital and ventilator-associated bacterial pneumonia (HABP/VABP), Zerbaxa ceftolozane/tazobactam...
...FDA), Silver Spring, Md. Yale University, New Haven, Conn. Erin McCallister, Senior Editor Relebactam/imipenem/cilastatin FDC Zerbaxa, ceftolozane/tazobactam (MK-7625A, cxa-201) Merck...

...Zerbaxa for bacterial pneumonia FDA approved an sNDA from Merck & Co. Inc. (NYSE:MRK) for Zerbaxa...
...for bacterial pneumonia FDA approved an sNDA from Merck & Co. Inc. (NYSE:MRK) for Zerbaxa ceftolozane/tazobactam...
...Editor Emgality, galcanezumab-gnlm (LY2951742) Invossa, TissueGene-C (invossa-k inj., tg-c) Vimizim, elosulfase alfa (BMN 110, bmn-110, galns) Zerbaxa, ceftolozane/tazobactam (MK-7625A, cxa-201) BioMarin...

...Merck & Co. Inc. (NYSE:MRK) said Zerbaxa ceftolozane/tazobactam met the primary endpoints in the Phase III...
...Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: Zerbaxa ceftolozane/tazobactam...
...days after the end of treatment Status: Phase III data Milestone: NA Brian Moy Zerbaxa, ceftolozane/tazobactam (MK-7625A, cxa-201) Astellas...

...Antibiotic Combination name Indication Astellas Pharma Inc. (Tokyo:4503); Merck & Co. Inc. (NYSE:MRK) Tazobactam Ceftolozane Zerbaxa...

...EMA’s CHMP recommended approval of Zerbaxa ceftolozane/tazobactam to treat complicated intra-abdominal infections (cIAIs), acute pyelonephritis and...
...Inc. (Tokyo:4503), Tokyo, Japan Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: Zerbaxa ceftolozane/tazobactam (formerly CXA-201...

...II data July; 2H15 Astellas Pharma Inc. (Tokyo:4503) / Merck & Co. Inc. (NYSE:MRK) Zerbaxa ceftolozane/tazobactam...

...a challenge and the unmet need is high. Recently, FDA approved a new antibiotic, Zerbaxa ceftolozane/tazobactam...

...in 2002 and plasma in 2005) Cubist Pharmaceuticals Inc. (NASDAQ:CBST) (B)/Astellas Pharma Inc. (Tokyo:4503) Zerbaxa ceftolozane/tazobactam...

...NMEs) plus two new combinations: HCV drug Viekira Pak from AbbVie Inc. and antibiotic Zerbaxa ceftolozane/tazobactam...

...to reduce the risk of transfusion-transmitted infections Cubist Pharmaceuticals Inc. (NASDAQ:CBST) (A) FDA approves Zerbaxa ceftolozane/tazobactam...